Shareholder Alert: Ademi LLP investigates whether Science 37 Holdings, Inc. has obtained a Fair Price in its transaction with eMed

Provided By PR Newswire

Last update: Jan 31, 2024

MILWAUKEE, Jan. 31, 2024 /PRNewswire/ -- Ademi LLP is investigating Science 37 (Nasdaq: SNCE) for possible breaches of fiduciary duty and other violations of law in its transaction with eMed.